Ectopic cell transplantation has been studied as an alternative to whole organ transplantation or as a method to produce secretable proteins for genetic disorders. In this study, bone marrow stromal cells isolated from C57Bl/6 mice were genetically modified to express either lacZ-or B-domain-deleted human factor VIII. In vitro modification of the isolated bone marrow stromal cells was initially performed by transducing increased doses of VSV-G pseudotyped lentiviral vectors expressing lacZ. At a MOI of 25, all of the bone marrow stromal cells were X-gal positive, which maintained their ability to expand and differentiate prior to transplantation into mice. Extremely poor engraftment was observed in the liver, but transplantation of the bone marrow stromal cells expressing lacZ under the kidney capsule resulted in long-term viable X-gal-positive cells for at least 8 weeks (length of study). In vitro expression of human factor VIII was detected in a dose-dependent manner following bone marrow stromal cell with a factor VIII-expressing lentiviral vector. Transplantation of the factor VIII-expressing bone marrow stromal cells under the kidney capsule led to long-term therapeutic expression in the mouse plasma (1-3 ng/ml; n = 4-5 mice/group) for 8 weeks. This study demonstrated that ectopic transplantation of bone marrow stromal cells under the kidney capsule can be effective as a method to express secretable proteins in vivo.
INTRODUCTION
To circumvent these issues, bone marrow-derived cells, which is a current area of intense research, may be used as an alternate source (6, 29) . Bone marrow stem The development of cell-based therapies to treat organ failures, such as the liver, has been studied as an cells can be divided into two main groups: hematopoietic and stromal cell lineages. In recent years, bone mar-alternate method to whole organ transplantation (9, 17, 21, 28) . Genetic modifications of primary hepatocytes row stromal stem cells have been found to be readily cultured in vitro and expanded for prolonged periods have been performed by numerous investigators using a variety of different vector systems. One of the main (6, 29) . An additional factor that would benefit ex vivo gene manipulation in transplantable cells would be to problems is that these cells are difficult to transduce in culture and propagation of these cells cannot be main-design vector systems that would maximize long-term, therapeutic expression of a transgene of interest. Previ-tained for longer than a few days (18, 22) . Moreover, these cells are not capable of efficient engraftment ous studies using naked DNA transfection of fibroblasts were performed by Roth et al. (31) prior to implantation within the liver following vascular infusion. To augment the number of transplanted cells that remain viable for into the upper omentum of mice. Although this approach was feasible, it is time consuming and required the need therapeutic efficacy, investigators have studied other extrahepatic sites for implantation, such as under the kid-to acquire cells following antibiotic selection, which could compromise the cells to some degree. Towards ney capsule (20) or within the mesentery (31). However, the ectopic transplantation results in relatively short-this end, the use of viral vectors, specifically simple and complex retroviruses, would be ideal due to their intrin-term survival for primary hepatocytes. Mouse stromal cells were plated in six-well dishes at simple retroviruses based on murine Moloney leukemia a density of 5 × 10 4 cells/well. The cells were transduced virus to genetically modify human bone marrow stromal in the presence of polybrene (8 µg/ml) with VSV-G cells to produce coagulation factor VIII (3, 4, 34) . Howpseudotyped lentiviral vectors expressing either lacZ-or ever, recent studies have shown that complex retrovi-B-domain-deleted human factor VIII. The medium was ruses based on human immunodeficiency virus type 1 changed 24 h after infection, and the cells were allowed were significantly more effective in transducing most to incubate for an additional 24 h prior to the fixation cell types compared to the MLV-based vectors (25) , inwith 0.1% glutaraldehyde. The cells were washed with cluding human bone marrow mesenchymal stem cells PBS and then stained with 4% X-gal solution for 24 h. (33). It remains to be determined whether genetically
The cells were photographed to observe the dose at manipulated bone marrow stromal cells through the use which the highest percentage of cells became X-gal posof lentiviral vectors can maintain their survivability and itive without having gross morphological changes. The capability to secrete proteins long term following transtransductions were performed in three independent explantation.
periments. The present study was designed to determine whether Ex Vivo Transplantation of Bone Marrow genetically modified bone marrow stromal cells using Stromal Cells lentiviral vectors can be efficiently transplanted under the kidney capsule. These studies should allow us to bet-LacZ and human factor VIII-expressing bone marrow ter understand whether these cells will be useful as a stromal cells were trypsinized and resuspended in a 1:1 factory to produce secretable proteins in vivo as a therapy. ratio of cold medium: liquid Matrigel (Becton Dickinson, Franklin Lakes, NJ). The cold medium contained MATERIALS AND METHODS RPMI with 0.7 mM EGTA and no calcium, which is the Animal Preparation normal medium used to expand the bone marrow stro-Male C57Bl/6 scid mice, 6-8 weeks old, were purmal cells. Because Matrigel polymerized quickly into a chased from a commercial vendor (Jackson Laborathree-dimensional gel at room temperature, all the procetories). All animal protocols were performed according dures involving Matrigel were performed at 4°C. Mice to the Louisiana State University animal facilities and were anesthetized with a mixture of ketamine and xylaz-NIH guidelines. Mice were anesthetized with a mixture ine, and then a flank incision was made in the mice. The of ketamine (100 mg/kg) and xylazine (2 mg/kg) prior kidneys were exposed and the cells were injected under to any surgical manipulation. Bone marrow stromal cells the kidney capsule. The mice were sutured and allowed (2-2.5 × 10 6 cells) were injected either directly into the to recover for the duration of the experiment. At differliver or under the kidney capsule using a 1:1 mixture of ent time points, the kidneys were harvested and snap RPMI and Matrigel. Mice were allowed to recover and frozen on O.C.T. embedding medium on dry ice for sechad ad libitum access to food and water for the duration tioning. The sections were fixed in 0.1% glutaraldehyde, of the experiment.
washed in PBS, and subsequently stained in 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal; Calbiochem) Isolation of Primary Mouse Marrow Stromal solution overnight. The stained kidney sections were Cells (MSCs) counterstained in hematoxylin and then dehydrated in Primary cultures of MSCs were obtained from the ethanol, rehydrated in xylene, and cover slipped to look femurs and tibias of adult male C57Bl/6 mice as prefor X-gal-positive cells under the kidney capsule by viously described (7, 27) . In brief, the long bones of mice light microscopy (n = 3/time point for animal sacrifice). were harvested aseptically and the ends of the bones ELISA for Human Factor VIII were removed and placed into a tube. The tube was centrifuged, the bones were removed, and the cell pellet Mouse blood was obtained via retro-orbital bleeding was resuspended prior to being triturated through a 21.5and placed into sodium citrate buffer. Plasma was isogauge needle and filtered through a 70-µm nylon filter. lated following centrifugation, and the human factor This suspension was then plated and the adherent cells VIII levels were measured by ELISA as described by were allowed to settle for 24 h. Afterwards, the cells the manufacturer's protocol (Affinity Biologicals, Hamwere washed with phosphate-buffered saline (PBS), and ilton, ON). fresh medium was used to replenish the cells. Four Lentiviral Vector Plasmids weeks later, the cells were trypsinized, replated, and passed three additional times before characterization to
The packaging construct, pCMV∆R8.74, and the envelope plasmid, pMD.G, have been previous described obtain a pure population of murine MSCs. GENETICALLY MODIFIED STROMAL CELLS FOR TRANSPLANTATION 639 (8) . The transfer plasmid, pHRSVcEF1αhFVIIIR(+) W(+), containing the B-domain-deleted human factor VIII cDNA driven by the EF1α promoter, was cloned using standard techniques. pHRSVcPGKnlsLacZS1.4(+) W(+) containing nuclear localized lacZ driven by the PGK promoter was previously described (30) . The revexpressing plasmid, pRSV121, was provided by Dr. T. J. Hope (University of Illinois, Champaign, Il). The packaging plasmid, pCMV.gag.pol.RRE.bpA, was cloned by standard techniques.
Lentiviral Production and Assays
The VSV-G pseudotyped lentiviral vectors were generated as previously described in our lab (24) (25) (26) 30) . In ing transfection, and 36 h later the conditioned medium was harvested, filtered, and concentrated by ultracentrifugation. The concentrated viral pellet was resuspended in PBS without calcium and magnesium containing 10 transduction in the bone marrow stromal cells, whereas µg/ml polybrene. The titer of the lentiviral vector stocks at higher MOI, the X-gal intensity was stronger, but less with the lacZ gene, serial dilution of concentrated virus cells were found in the plate, suggesting cellular toxicity was used to infect 5 × 10 5 HeLa in a six-well plate in associated with the lentiviral vector likely due to the the presence of polybrene (8 µg/ml). Blue cells were well-known fusogenic effects of the VSV-G envelope counted following X-gal staining to determine the lencoat protein. One additional feature that we noted was tiviral vector titer. For the lentiviral vector containing that the transduced marrow stromal cells could maintain the factor VIII gene, the titer of the vector prep was their plasticity in culture, because they could still differdetermined by ELISA for the p24 Gag antigen concenentiate into either adipocytes or osteocytes depending on tration (Alliance; Dupont-NEN).
the applied culture medium. We observed this phenomenon on three separate occasions using two different RESULTS preparations of the lentiviral vector (data not shown).
In Vitro Analysis on the Efficiency of Lentiviral Vector Ex Vivo Analysis of Bone Marrow Stromal Cell Transduction of Murine Bone Marrow Stromal Cells
Viability Injected Into the Liver Conditioned medium containing VSV-G pseudotyped lentiviral vectors was titered by end-point dilution on Initial experiments in our lab attempted to transplant the lentiviral vector-transduced bone marrow stromal HeLa cells. In our preliminary experiment to assess the transduction efficiency of lentiviral vectors into the mu-cells into the parenchyma of the liver by either direct injection or by infusion through the portal vein. The rine bone marrow stromal cells, we transduced a range of MOI from 1, 5, 10, 25, 50, and 100 in triplicate. We marrow stromal cells (MOI 25) as shown in Figure 1 were expanded and were infused into mouse livers by found highly efficient lentiviral vector transduction of murine bone marrow stromal cells isolated from C57Bl/ portal vein injection using 1, 5, or 10 × 10 6 cells (n = 3-4 mouse/cell number). We found a rare number of X-6 mice was observed as determined by qualitative assessment of the cells following glutaraldehyde fixation gal-positive cells in the liver sections (data not shown), but we did observe a few X-gal-positive cells in the and subsequent X-gal staining. Figure 1 demonstrates bone marrow stromal cells infected at a MOI of 25 with spleen. In our hands, the maximal number of cells that could be safely administered by direct portal vein infu-a lacZ-expressing lentiviral vectors. No X-gal-positive cells were detectable in vehicle or EGFP-expressing len-sion was 1 × 10 6 as higher numbers of cells appeared to result in mortality of the mice likely due to the blockage tiviral vector transduced bone marrow stromal cells (data not shown). At the MOI of 25, no visible cyto-of blood vessels by the stromal cells, which are a relatively large cell in terms of diameter. pathic effects were found following lentiviral vector On the other hand, we found more abundant numbers gly transduced MSCs produced higher levels of hFVIII. As a control cell line, we infected HeLa cells to demon-of X-gal-positive cells compared to the portal vein approach, but the numbers were still extremely low when strate the ability of lentiviral vectors to transduce and express human factor VIII. a direct injection of bone marrow stromal cells was performed into the mouse liver parenchyma. Figure 2A and Overall, the results of our study demonstrated the potential benefit of genetically manipulating bone marrow B shows liver sections from two different mice (out of the four mice that were infused) demonstrating liver en-stromal cells using VSV-G pseudotyped lentiviral vectors. graftment or cell fusion of the lacZ-expressing marrow
In Vivo Expression of Human Factor VIII stromal cells after 7 days following transplantation. In in Mouse Plasma Following Transplantation some liver sections, there was significant liver damage, Under the Kidney Capsule likely due to the injection process either the needle or the placement of the cells into the liver parenchyma.
Therapeutic levels of plasma human factor VIII was measured by ELISA in C57Bl/6 scid mice transplanted Ex Vivo Analysis of Bone Marrow Stromal Cell with 2.5 × 10 6 stromal cells/kidney (n = 4-5 mice/ Viability Under the Kidney Capsule group) at 8 weeks postimplantation (Fig. 4) . The bone marrow stromal cells were transduced either once or Due to the low number of marrow stromal cells engrafted or fused in the liver, we examined an ectopic twice with factor VIII-expressing lentiviral vectors, and the double-transduced cells led to plasma factor VIII site to transplant the lentiviral vector-transduced marrow stromal cells. The space under the kidney capsule was levels of 1.8 ± 0.4 ng/ml, which was ϳ50% higher than the single transduced cells at the 8-week time point. No an ideal storage place due to the large number of cells that can be readily implanted and its known survivabil-detectable levels of plasma factor VIII was observed in vehicle or lacZ transduced bone marrow stromal cells ity. Between 2 and 2.5 × 10 6 stromal cells mixed in a Matrigel solution were injected under each of the kidney under the kidney capsule. This may become a viable method to express coagulation factor VIII as well as capsules, and the kidneys were harvested every 2 weeks (n = 3/time point). The kidneys were sectioned and other secretable proteins using this relatively simple ex vivo approach. stained with X-gal solution to qualitatively determine the cell survivability following transplantation. Over the DISCUSSION 8-week period, the transplanted cells appeared to survive as shown by the high number of X-gal-positive cells.
The present study demonstrates the relatively simple process of genetically modifying bone marrow stromal Interestingly, ossicle formation was found to occur beginning at 2 weeks, and was clearly evident by week cells using advanced generation lentiviral vectors pseudotyped with the VSV-G envelope coat protein. To 4 throughout the subsequent time points. This type of differentiation has been previously shown to develop transplant cells following genetic manipulation, it is imperative to obtain cells that have stable integration of following hematopoietic stem cell transplantation under the renal capsule. No X-gal-positive cells were found in the transgene of interest, otherwise any cellular proliferation by the implanted cells will result in long-term loss EGFP-transduced stromal cells, demonstrating the specificity of the lacZ expression (data not shown).
of signal. Previous studies have used transfection of naked DNA into isolated primary fibroblasts to express In Vitro Detection of Human Factor VIII in Lentiviral secretable proteins, such as human factor VIII, following Vector Transduced Bone Marrow Stromal Cells implantation into the mesentery (31). However, these isolated cells needed to be selected by antibiotic resis-To determine whether our genetically modified bone marrow stromal cells could express human factor VIII tance over several week period prior to transplantation. This type of approach limits the types of cells that can in culture, we transduced and expanded these cells following transduction with an advanced third-generation be manipulated due to the long time course needed to isolate a pure population of modified cells. lentiviral vectors expressing the B-domain-deleted human factor VIII cDNA driven by the EF1α promoter.
Towards this end, viral vectors that have intrinsic capabilities to integrate into the host genome are pre-As shown in Figure 3 , we found that human factor VIII could be dose-dependently produced following len-ferred, but have not been widely tested on cells, such as bone marrow stromal cells. Simple and complex retrovi-tiviral vector transduction. Importantly, we found that these lentiviral vector-transduced marrow stromal cells ral vectors appear to be highly useful for these types of experiments because cell division would not adversely could be frozen, thawed, and expanded at later time points (i.e., several weeks later) to produce similar levels affect the ability of this vector system to persist, unlike other episomal vector systems. Previous studies have of human factor VIII (hatched vs. dark gray bar). In addition, we found that additional transduction into the sin-used murine Moloney-based retroviral (MLV) vectors to In vitro transduction of murine bone marrow stromal cells with lentiviral vectors containing the human factor VIII (B-domain deleted) gene. Bone marrow stromal cells (5 × 10 4 cells) were transduced with increasing doses (between 4.5 and 18 µg p24 Gag protein) of VSV-G pseudotyped lentiviral vectors containing the B-domain-deleted human factor VIII gene. Medium was collected 96 h following transduction into bone marrow stromal cells and the medium was tested for the detection of human factor VIII levels by ELISA. HeLa cells (black bar; 0.9 µg p24) were used as a control for lentiviral vector transduction and human factor VIII expression. The hatched bar shows that MSCs are readily frozen and expandable allowing for repeated use after infection (in comparison to gray bar).
transfer expressible transgenes into bone marrow stro-marrow stromal cells were found to readily secrete significant levels of human factor VIII in vitro (3, 4, 34) . mal cells (3, 4, 12, 32, 34) . Schwarz et al. (32) demonstrated that MLV vectors can effectively transduce rat However, in vivo studies by Chuah et al. (4) found that retroviral vector-transduced stromal cells expressed fac-marrow stromal cells to produce two different genes that were necessary to efficiently synthesize L-DOPA. These tor VIII transiently following splenic implantation. One reason for this is the well-known transcriptional silenc-stromal cells were capable of expansion and proliferation without any loss of its ability to produce the gene of ing that occurs through a phenomenon known as position effect variegation (23) , which precludes using these interest. In other studies, MLV vector-transduced bone vectors for long-term expression studies. Although early engraftment of primary cells for a wide range of study from basic biological processes involved in differentia-generation complex retroviruses have shown downregulation problems, it has been shown that deletions within tion to its use as a protein secretion factory (11, 20, 35) . Previous studies by investigators have shown that bone the U3 region can alleviate the promoter interference (10) . A more recent issue that may preclude the use of marrow cells can be effectively transplanted beneath the kidney capsule for over 6 months (i.e., up to 192 days) simple retroviruses is the leukemogenesis that developed in the several of the young children enrolled in the X- (35) . Moreover, Gurevitch et al. (11) have suggested that the stromal cell microenvironment helps to promote en-linked SCID trials following genetic manipulation of human hematopoietic stem cells using MLV-based retrovi-graftment in ectopic sites, such as under the kidney capsule. Other investigators have transplanted hepatocytes ral vectors (13).
Lentiviral vectors, which are complex retroviruses, into the kidney capsule to produce secretable proteins (20) . As an alternative ectopic site for the transplantation have been found to be more efficient than MLV-based retroviral vectors in transducing a wider number of cell of bone marrow stromal cells in the production of human factor VIII could be into the subcutaneous fat. A types provided that the VSV-G envelope coat protein is utilized during vector production (25) . The findings in recent study by Ogata et al. (19) using a lentiviral vector derived from monkeys found that human factor VIII can our study demonstrate that VSV-G pseudotyped lentiviral vectors are a reliable and effective vehicle to trans-be secreted from adipocytes. Because the lentiviral vector-transduced bone marrow stromal cells can still dif-duce isolated bone marrow stromal cells from mice, and this suggests that this method may have potential as a ferentiate into adipocytes, the transplantation into fat pads may be another alternative method to produce se-cell therapy application in humans. In comparison, a previous study by Totsugawa et al. (33) found that an cretable proteins, especially because the injection sites would be more prevalent than the kidney capsule. early generation lentiviral vector system could transduce bone marrow mesenchymal stem cells (ϳ40% efficiency)
Our present study demonstrates that bone marrow stromal cells are flexible in the use as a factory to ex-originating from humans.
Although there are safety questions on the use of len-press secretable proteins compared to other cells, such as primary hepatocytes. First, the transduction efficiency tiviral vectors in humans, there is recent in vitro promoter trapping experiments that have shown an integra-into mouse bone marrow stromal cells is significantly higher than murine primary hepatocytes (18, 22) . Sec-tion pattern by lentiviral vectors that differs greatly from MLV-based vectors, in which lentiviral vectors were ond, bone marrow stromal cells can be serially passaged as well as frozen prior to expansion in cell culture for found to integrate distal to the promoter (5) . This type of integration pattern should minimize the possibility of transplantation into an ectopic site. Third, genetic manipulation with lentiviral vectors appears to be readily insertional mutagenesis leading to the activation of oncogenes. The other important point to make is that len-efficient compared to primary hepatocytes, which can have significant toxicity associated with the vector prep-tiviral vectors are now in Phase I/II of human clinical trials in which the investigators are attempting to ad-arations even at subsaturating doses. Future studies will need to consider manipulations of dress the issue of safety and efficacy of this system as a future medical therapeutic (1,14,15). As far as we are the coding sequence to maximize circulating levels of a secreted protein (i.e., insertion of a proteolytic site at aware, our current study is the first to use modified lentiviral vectors to transduce bone marrow stromal cells to amino acid 1648) (2) . Recent studies by Miao et al. (16) have described a modified B-domain-deleted human fac-express a secretable protein, such as human factor VIII, in vivo by transplanting the cells under the kidney capsule.
tor VIII that can be secreted 15-25 times more efficiently than the full-length human factor VIII protein in Although the preferred site of coagulation factor VIII production would be hepatocytes, which are the normal vitro and in vivo. The optimization of a vector system to genetically modify a cell type, such as bone marrow synthesis site in the body, the ability of hepatocytes or other types of cells, including stems cells, has been ex-cells, as well as inserting a highly efficient protein will be important to determine the utility of cell-based trans-tremely difficult to achieve. However, there is a recent study demonstrating that cells committed to the myelo-plantation experiments. In all, we have shown that bone marrow stromal cells monocytic lineage can be found to fuse to hepatocytes following splenic transplantation (36) . The isolation of isolated from C57Bl/6 mice can be effectively transplanted under the kidney capsule for at least 8 weeks cells for this method is laborious and time consuming, in contrast to the techniques described in this current and survive in sufficient numbers to produce low but therapeutic levels of secretable coagulation factors into study using easily obtainable bone marrow stromal cells. In our approach, the transplantation of marrow stromal the circulation. Future studies will need to optimize and enhance the secreted protein levels, and potentially mod-cells under the kidney capsule has been shown to allow 
